Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases

In 1995, the European Society for Paediatric Infectious Diseases (ESPID) carried out a survey of its members to assess the variation in management of respiratory syncytial virus (RSV) bronchiolitis. The aim of the current study was to carry out a similar survey 20 years later to assess how the manag...

Full description

Saved in:
Bibliographic Details
Main Authors: Elliott J. Carande, Andrew J. Pollard, Simon B. Drysdale
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2016/9139537
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558882036121600
author Elliott J. Carande
Andrew J. Pollard
Simon B. Drysdale
author_facet Elliott J. Carande
Andrew J. Pollard
Simon B. Drysdale
author_sort Elliott J. Carande
collection DOAJ
description In 1995, the European Society for Paediatric Infectious Diseases (ESPID) carried out a survey of its members to assess the variation in management of respiratory syncytial virus (RSV) bronchiolitis. The aim of the current study was to carry out a similar survey 20 years later to assess how the management had changed. An electronic, structured, English language survey, based on the United Kingdom National Institute for Health and Care Excellence (NICE) bronchiolitis draft guideline, was sent to ESPID members in March 2015. Questions asked included information on treatment practices of infants with bronchiolitis and doctor demographics. We received responses from 135 doctors (14% of the ESPID members) who worked in 115 hospitals. 56% of the doctors used a written guideline to manage bronchiolitic infants. All doctors stated that they isolated individually or in cohorts all hospitalised bronchiolitis infants. The level of oxygen saturation suggested as an indication to administer supplemental oxygen varied between <89% and <95%. We found significant reductions in the use of ribavirin, bronchodilators, and corticosteroids from 1995 to 2015 (ribavirin 57% to 13%, P<0.0001; bronchodilators 95% to 82%, P=0.0024; corticosteroids 81% to 45%, P<0.0001). Although variability in management remains high, encouragingly significantly fewer doctors are prescribing ribavirin, bronchodilators, and corticosteroids compared to 20 years ago.
format Article
id doaj-art-a04edf072a444df0ab9b7fc5cb6b6a35
institution Kabale University
issn 1712-9532
1918-1493
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-a04edf072a444df0ab9b7fc5cb6b6a352025-02-03T01:31:19ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95321918-14932016-01-01201610.1155/2016/91395379139537Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious DiseasesElliott J. Carande0Andrew J. Pollard1Simon B. Drysdale2Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Level 2, Children’s Hospital, Oxford OX3 9DU, UKOxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Level 2, Children’s Hospital, Oxford OX3 9DU, UKOxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Level 2, Children’s Hospital, Oxford OX3 9DU, UKIn 1995, the European Society for Paediatric Infectious Diseases (ESPID) carried out a survey of its members to assess the variation in management of respiratory syncytial virus (RSV) bronchiolitis. The aim of the current study was to carry out a similar survey 20 years later to assess how the management had changed. An electronic, structured, English language survey, based on the United Kingdom National Institute for Health and Care Excellence (NICE) bronchiolitis draft guideline, was sent to ESPID members in March 2015. Questions asked included information on treatment practices of infants with bronchiolitis and doctor demographics. We received responses from 135 doctors (14% of the ESPID members) who worked in 115 hospitals. 56% of the doctors used a written guideline to manage bronchiolitic infants. All doctors stated that they isolated individually or in cohorts all hospitalised bronchiolitis infants. The level of oxygen saturation suggested as an indication to administer supplemental oxygen varied between <89% and <95%. We found significant reductions in the use of ribavirin, bronchodilators, and corticosteroids from 1995 to 2015 (ribavirin 57% to 13%, P<0.0001; bronchodilators 95% to 82%, P=0.0024; corticosteroids 81% to 45%, P<0.0001). Although variability in management remains high, encouragingly significantly fewer doctors are prescribing ribavirin, bronchodilators, and corticosteroids compared to 20 years ago.http://dx.doi.org/10.1155/2016/9139537
spellingShingle Elliott J. Carande
Andrew J. Pollard
Simon B. Drysdale
Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases
Canadian Journal of Infectious Diseases and Medical Microbiology
title Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases
title_full Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases
title_fullStr Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases
title_full_unstemmed Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases
title_short Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases
title_sort management of respiratory syncytial virus bronchiolitis 2015 survey of members of the european society for paediatric infectious diseases
url http://dx.doi.org/10.1155/2016/9139537
work_keys_str_mv AT elliottjcarande managementofrespiratorysyncytialvirusbronchiolitis2015surveyofmembersoftheeuropeansocietyforpaediatricinfectiousdiseases
AT andrewjpollard managementofrespiratorysyncytialvirusbronchiolitis2015surveyofmembersoftheeuropeansocietyforpaediatricinfectiousdiseases
AT simonbdrysdale managementofrespiratorysyncytialvirusbronchiolitis2015surveyofmembersoftheeuropeansocietyforpaediatricinfectiousdiseases